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Candida albicans 
(Proteome)
Total protein Annotated 
(known) protein
Hypothetical 
protein
Uncharacterized 
ORF (unknown)
No. % No. % No. %
Candida albicans [SC
5314] 14633 3991 27.27 10600 72.44 38 0.26
Unique proteins
against Human 4568 587 12.85 3954 86.56 27 0.59
Unique proteins
against S. cerevisiae 2955 198 6.7 2732 92.45 25 0.85
Table 1. Summary of total predicted unique proteins of C. albicans categorized quantitatively
under different classes.
Functional class Unique  against Human 
proteome
Unique against S. cerevisiae
proteome
Enzyme 132 37
Transcription factor 96 11
Receptor 4 0
Transport protein 29 6
Table 2. Known or annotated unique proteins of C. albicans predicted against Human and
S. cerevisiae classified into major functional classes.
Figure 2. Snapshot of CaTargetDB showing Home page.
Figure 3. Snapshot of CaTargetDB database showing details of predicted unique
protein.
Figure. 1 Unique proteins of C. albicans deciphered after BLAST similarity search against
Human and S. cerevisiae.
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 The protein sequences (14633) of C. albicans retrieved through RefSeq, an experimentally curated reference
sequence database at NCBI.
 To explore the unique proteins, proteome of C. albicans was first compared against human proteome and then
with S. cerevisiae (Yeast) through BLAST (Altschul, et. al)program (NCBI).
 The minimum expect value was set 10 with gap penalties existence 11 and extension 1 for. BLAST similarity
search. To find true homology, we have used BLOSUM62 substitution matrix.
 We have found, out of 14633 proteins of C. albicans, 4568 proteins resulted unique or essential to Candida and
not showed any similarity with Human proteome. Similarly 2955 proteins resulted unique against S. cerevisiae
(Fig. 1).
 Further unique proteins have been categorized into three major classes- annotated, hypothetical and
uncharacterized ORF/unknown (Table 1).
 Results showed that like proteome of C. albicans which comprises 72.44% hypothetical protein, predicted
unique proteins of Candida against Human and S. cerevisiae indicate higher ratio of hypothetical proteins viz.,
86.56%and 92.45% respectively.
 Results showed that large number of unique proteins are still uncharacterized & unexplored functionally.
 Most of the unique proteins predicted functionally unknown or uncharacterized ORF .
 Annotated or known unique proteins were classified into different functional class of drug targets (Table 2).
 Most of the unique proteins were classified under enzyme category followed by transcription factors,
transporters and receptor (Table 2).
 Additionally we have elucidated domain, motif and family of predicted unique/essential proteins of Candida by
using CDD (NCBI), PROSITE, Pfamdatabases.
 All the predicted results as well as experimental data have been compiled in to database named ‘CaTargetDB’,
available at CIMAP local network (LAN). Snap shots are shown in Figure 2 & 3.
 In order to identify novel antifungal drug targets in C. albicans, two level of virtual screening used to find out
actualtarget, that may not hinder with host as well as commensal flora of human gastrointestinal tract.
 Result showed that 31.22% of Candida unique proteins showed no similarity with human proteome, thus
called unique or essential protein. Similarly, 20.19% of Candida unique proteins showed no similarity with S.
cerevisiae proteome.
 Unique proteins were dominated by hypothetical proteins.
 We concluded that unique proteins under enzyme, receptor, transcription factor & transporter categories are
likely to be a potential antifungal drug target against C. albicans .
 Existing drug targets and predicted unique proteins of Candida through comparative genomics approach are
available at ‘CaTargetDB’ database at CIMAP local LAN network.
Candida albicans, an opportunistic flora inhabitant of human gastrointestinal tract with no pathogenic consequence in healthy people. However, it causes severe mucosal infection and sometimes
systemic infection leading to candidiasis in immunocompromised patient. Development of antifungal resistance adding more concern and render us to find novel and potential antifungal targets that
could lead to develop effective antifungal drug. Existing way to identify potential targets rely on specific subsets like virulence genes, species-specific genes, uncharacterized essential genes, unique
enzymes, membrane transporters etc (Galperin and Koonin, 1999). However, comparative genomics approach uses genome wide screening of potential targets including all functional categories. More
precisely, these can be further classified into different groups like enzyme, transporter, receptor, transcription factors etc. In the present study, we have used comparative genomics approach to identify
novel drug targets in C. albicans. We have analyzed 14,633 proteins of C. albicans proteome and after comparison with human proteome, we have predicted 4,568 unique proteins. The proteins of C.
albicans not showing significant homology to human and S. cerevisiae proteomes were termed as unique proteins. Predicted as well as experimental data have been compiled in the form of CaTargetDB
database which is accessible at LAN of CIMAP.
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